Top Medical News

Chronic Immune-Related Adverse Events Are Common in Certain Melanoma Subgroups

April 17th 2021

Chronic immune-related adverse effects arising from adjuvant anti–PD-1 therapy in patients with high-risk melanoma are more common than previously recognized, and often persisted with longer follow-up.

A Chat on Communication Barriers in Childhood Cancer

April 16th 2021

FDA Approves Frontline Nivolumab for Gastric Cancers

April 16th 2021

The FDA approved nivolumab (Opdivo) plus certain types of chemotherapy for the treatment of patients with advanced or metastatic gastric cancer, gastroesophageal junction (GEJ) cancer, and esophageal adenocarcinoma.

Approach Health Disparities From All Angles

April 16th 2021

April is National Minority Health Month, highlighting the need for health care and community sectors to come together and improve cancer outcomes for underserved populations.

Dual Diagnosis: Nurses Face Challenges in Caring for Patients With Both Cancer and Diabetes

April 15th 2021

Nurses need to know these key concepts when treating patients who have diagnoses of both cancer and diabetes.


Most Recent